Prostate cancer is one of the most common cancers that occur in men. While it can be life-threatening, the disease is ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

Assessment of prostate-specific antigen (PSA) level for three months after radical prostatectomy (RP) for prostate ...

Men who avoided prostate cancer screening appointments were significantly more likely to die from the disease, according to ...

A recent breakthrough study highlights how a simple at-home urine test could accurately detect prostate cancer. Researchers ...

Onconetix (ONCO) announced that new clinical data of Proclarix was presented on March 23, 2025 during the 2025 European ...

A new study has revealed that men who don't heed recommendations for prostate cancer screenings are at a significantly higher ...

Investigators found that higher persistent PSA levels after surgery were linked to a worse prognosis, underscoring the ...

A new at-home saliva test could help identify men with a high risk of prostate cancer more accurately than blood tests, leading to earlier diagnosis and more successful treatment. Prostate cancer ...

and those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. Gozellix® is a novel product which provides a longer shelf life of up to six hours and an extended ...